WELL Health Technologies named “Best Idea” at TD Cowen

TD Cowen analyst David Kwan maintained a “Buy” rating and C$7.50 target price on WELL Health Technologies  (WELL Health Sto...

Nick Waddell 6 hours ago
WELL:CA
  • Pinterest named a top pick by this fund manager

    Tara Whittet 7 hours ago
    PINS
  • This Canadian mining technology stock is one to watch, Haywood says

    Nick Waddell 9 hours ago
    MHUB:CA
  • Intermap Technologies wins price target raise at Beacon

    Tara Whittet 23 hours ago
    IMP:CA
  • Firefly Aerospace stock is a buy, this analyst says

    Rod Weatherbie 23 hours ago
    FLY
  • Should you sell your MDA Space stock?

    Rod Weatherbie 24 hours ago
    MDA:CA
  • This small Canadian security stock is a buy, analyst says

    Nick Waddell 2 days ago
    XTRA:CA
  • RBC trims price target on Enghouse Systems

    Rod Weatherbie 3 days ago
    ENGH:CA
  • This small Canadian healthcare stock is one to watch, analyst says

    Nick Waddell 3 days ago
    NURS:CA
  • Is Zscaler stock a buy right now?

    Tara Whittet 3 days ago
    ZS

WELL Health Technologies named “Best Idea” at TD Cowen

TD Cowen analyst David Kwan maintained a “Buy” rating and C$7.50 target price on WELL Health Technologies  (WELL Health Stock Quote, Chart, News, Analysts, Financials TSX:WELL) in the firm’s Canada Best Ideas 2025 report, calling the recent pullback...

WELL:CA
6 hours ago
  • WELL Health Technologies’ opportunity is huge, Stifel says

    Nick Waddell August 22, 2025
    WELL:CA
  • Rubicon Organics wins price target raise at Haywood

    Staff August 20, 2025
    ROMJ:CA
  • This analyst just raised his price target on WELL Health Technologies

    Rod Weatherbie August 18, 2025
    WELL:CA

More News

  • Ambarella wins price target raise at Roth

    Staff September 2, 2025
    AMBA
  • Novo Nordisk is undervalued, this fund manager says

    Rod Weatherbie September 2, 2025
    NVO
  • The risk-to-return on NTG Clarity Networks is incredible, Beacon Securities says

    Rod Weatherbie September 2, 2025
    NCI:CA
  • NervGen Pharma price target chopped at Research Capital

    Rod Weatherbie September 2, 2025
    NGEN:CA
  • Theralase Technologies is very undervalued, this analyst says

    Nick Waddell September 2, 2025
    TLT:CA
  • Sabio Q2 gets thumbs up at Paradigm Capital

    Nick Waddell August 29, 2025
    SBIO:CA
  • Analyst chops price target on this Canadian banking stock

    Rod Weatherbie August 29, 2025
    EQB:CA
  • Is Lantronix stock still a buy?

    Nick Waddell August 29, 2025
    LTRX
  • This Canadian security stock is a buy, analyst says

    Rod Weatherbie August 28, 2025
    XX:CA
displaying rededs